"As its shares changed hands at $6.50, valuing the Massachusetts-based company at around £800m, dealers heard whispers from across the Pond that at least three international pharma groups including US giant Eli Lilly have made ‘friendly approaches’ to the Ariad board and are prepared to pay up to $20 a share in cash to gain control.
Read more: www.dailymail.co.uk/money/markets/...-Ariad.html#ixzz2rAYwPQvr
Follow us: @MailOnline on Twitter | DailyMail on Facebook"
Read more: www.dailymail.co.uk/money/markets/...-Ariad.html#ixzz2rAYwPQvr
Follow us: @MailOnline on Twitter | DailyMail on Facebook"
Werbung